Affordable Access

Access to the full text

Pain management in patients with end-stage renal disease and calciphylaxis- a survey of clinical practices among physicians

Authors
  • Chinnadurai, Rajkumar1
  • Sinha, Smeeta1
  • Lowney, Aoife C2, 3
  • Miller, Mary2, 3
  • 1 Salford Royal NHS Foundation Trust, Salford, M6 8HD, UK , Salford (United Kingdom)
  • 2 Sir Michael Sobell House Hospice, Oxford, UK , Oxford (United Kingdom)
  • 3 Oxford University Hospitals NHS Foundation Trust, Oxford, UK , Oxford (United Kingdom)
Type
Published Article
Journal
BMC Nephrology
Publisher
Springer (Biomed Central Ltd.)
Publication Date
Sep 18, 2020
Volume
21
Issue
1
Identifiers
DOI: 10.1186/s12882-020-02067-2
Source
Springer Nature
Keywords
License
Green

Abstract

BackgroundCalciphylaxis is a rare condition usually seen in patients with end-stage renal disease. Pain is a hallmark of this condition and can be extremely difficult to control. Anecdotal data suggests that pain management in calciphylaxis is challenging with variable approaches across the United Kingdom (UK) and internationally. A knowledge and practice survey was conducted to establish current practice in the management of pain in patients with calciphylaxis, in the UK. Based on the results and clinical experience the authors suggest a clinical practice guideline.MethodsAn online questionnaire was circulated among physicians (renal and palliative care) involved in the management of pain in calciphylaxis. The questionnaire included a mix of open-ended questions and questions with drop down options.ResultsOne hundred and six clinicians responded to the survey of which 60 (57%) respondents were from palliative medicine; the remaining 46 (43%) were from renal medicine. 31 (30%) respondents across both specialties had not encountered any patients with a diagnosis of calciphylaxis (renal-2, palliative care-29). A referral to the palliative care team was undertaken by 18% of renal physicians, 32% referred to the pain team and 50% referred to both. Only 3% of the palliative medicine respondents indicated that they had received a referral from the renal team at the time of diagnosis. Opioids were the preferred initial drug of choice for the management of all types of pain. Paracetamol was universally selected as the preferred first-choice adjuvant agent for management of all types of pain. The importance of advance care planning was highlighted with 72% undertaking advanced care planning discussions often or most of the time.ConclusionThere was wide variation in the current practice of pain management in patients with calciphylaxis, with variation between renal specialists and palliative care specialists. Referral to specialists in pain management is not universal despite the severe nature of the pain experienced by patients with calciphylaxis. The data generated has facilitated the development of a clinical practice guideline to support complex pain management in a group of patients with multiple comorbidities.

Report this publication

Statistics

Seen <100 times